Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology

MicroRNAs (miRNAs) are small noncoding RNAs that are 19-24 nucleotides in length, following maturation. Recent evidence has demonstrated their key role as post-transcriptional regulators of gene expression through the binding of specific sequences within target messenger RNA (mRNA). miRNAs are invol...

Full description

Saved in:
Bibliographic Details
Other Authors: Fioravanti, Antonella (Editor), Dotta, Francesco (Editor), Giordano, Antonio (Editor), Pirtoli, Luigi (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_68654
005 20210501
003 oapen
006 m o d
007 cr|mn|---annan
008 20210501s2020 xx |||||o ||| 0|eng d
020 |a books978-3-03936-331-5 
020 |a 9783039363308 
020 |a 9783039363315 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03936-331-5  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Fioravanti, Antonella  |4 edt 
700 1 |a Dotta, Francesco  |4 edt 
700 1 |a Giordano, Antonio  |4 edt 
700 1 |a Pirtoli, Luigi  |4 edt 
700 1 |a Fioravanti, Antonella  |4 oth 
700 1 |a Dotta, Francesco  |4 oth 
700 1 |a Giordano, Antonio  |4 oth 
700 1 |a Pirtoli, Luigi  |4 oth 
245 1 0 |a Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (320 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a MicroRNAs (miRNAs) are small noncoding RNAs that are 19-24 nucleotides in length, following maturation. Recent evidence has demonstrated their key role as post-transcriptional regulators of gene expression through the binding of specific sequences within target messenger RNA (mRNA). miRNAs are involved in the synthesis of a very large number of proteins, and it is speculated that they could regulate up to 30% of the human genome. They control virtually every cellular process and are essential for animal development, cell differentiation, and homeostasis. Altered miRNA expression has been linked to such pathological events as inflammatory, degenerative, or autoimmune processes and have been associated with several diseases, including cancer, cardiovascular diseases, diabetes mellitus, and rheumatic and neurological disorders. Recently, miRNAs have been found in many different biological fluids, and this observation suggests the potential of miRNAs as new candidate biomarkers for diagnosis, classification, prognosis, and responsiveness in the treatment of different pathological conditions. Furthermore, the development of therapeutic strategies that involve either restoring or repressing miRNAs expression and activity has attracted much attention. Significant progress has been made in the systems for delivery of miRNAs, even if substantial improvements in this area are still necessary. Although they have been extensively studied, a number of interesting questions regarding the physiological and pathological role of miRNAs have been postulated, and their potential diagnostic and therapeutic role remain yet unanswered. Reactive oxygen species (ROS) are free radical-containing oxygen molecules derived from cellular oxidative metabolism, including enzyme activities and mitochondrial respiration, and play a pivotal role in many cellular functions. Whereas ROS are essential for normal cellular processes, their aberrant production, or failure of the capacity to scavenge excessive ROS, induces an altered redox status with excessive synthesis of free radicals, leading to an imbalance in the redox environment of the cell. The loss of normal ROS levels causes lipid, protein, and DNA damage, which contribute to the development of various pathologies including neurological disorders, rheumatic and cardiovascular diseases, diabetes, and cancer. Increasing evidence highlights that there is crosstalk between miRNAs and components of redox signaling, even if this complex and the characteristics of mutual interaction need to be amply elucidated. Hence, both miRNAs and oxidative stress are involved in the multifactorial development and progression of acute and chronic diseases by influencing numerous signaling and metabolic pathways. The Special Issue entitled "Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology" of the International Journal of Molecular Sciences includes original articles and reviews that provide new insights into the interaction between miRNAs and oxidative stress under normal and pathological conditions which can assist in the development of new therapeutic strategies. Finally, I would like to thank all the authors for their excellent contribution. I hope this Special Issue will provide readers with updated knowledge about the role of miRNAs and oxidative stress in physiology and pathology. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a miR-27a-5p 
653 |a acute myocardial infarction 
653 |a autophagy 
653 |a apoptosis 
653 |a hypoxia 
653 |a MicroRNA (miRNA) 
653 |a miR526b 
653 |a miR655 
653 |a oxidative stress 
653 |a reactive oxygen species (ROS) 
653 |a superoxide (SO) 
653 |a Thioredoxin Reductase 1 (TXNRD1) 
653 |a breast cancer 
653 |a nucleic acid medicine 
653 |a pancreatic cancer 
653 |a clinical trial 
653 |a siRNA 
653 |a antisense oligonucleotide 
653 |a MicroRNA 
653 |a signal transduction 
653 |a therapeutic target 
653 |a miRNAs 
653 |a ROS 
653 |a noncoding RNA 
653 |a microRNA 
653 |a long noncoding RNA 
653 |a mitochondrial dysfunction 
653 |a nitrosative stress. exosome 
653 |a cross-talk 
653 |a systemic lupus erythematosus 
653 |a visfatin 
653 |a resistin 
653 |a osteoarthritis 
653 |a synovial fibroblasts 
653 |a synovitis 
653 |a NF-κB 
653 |a thyroid hormone 
653 |a liver cancer 
653 |a metabolism 
653 |a physiology 
653 |a ASH 
653 |a NAFLD 
653 |a NASH 
653 |a HCC 
653 |a HCV 
653 |a HBV 
653 |a endometriosis 
653 |a high-grade serous ovarian cancer 
653 |a endometriosis-associated ovarian cancer 
653 |a epithelial-to-mesenchymal transition 
653 |a chemoresistance 
653 |a antioxidants 
653 |a miRNA 
653 |a cancer 
653 |a diabetes 
653 |a beta cells 
653 |a microRNAs 
653 |a translation regulation 
653 |a neurodegeneration 
653 |a Alzheimer's disease 
653 |a Parkinson's disease 
653 |a Huntington's disease 
653 |a ALS 
653 |a reactive oxygen species 
653 |a redox signaling 
653 |a therapeutic tolerance 
653 |a therapeutic resistance 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/2416  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/68654  |7 0  |z DOAB: description of the publication